ESCMID weekly news 15.02.2022

15 February 2022: ESCMID Weekly
Having trouble viewing this email? View in your browser.

 

Weekly News
15 February 2022

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 

ECCMID 2022 Late(breaker) abstract submission closes tomorrow!

Less than 24 hours are left to submit your late regular and late-breaker abstracts to ECCMID 2022!
 

Be sure to get your submission completed by tomorrow, 16 February 2022 at 15:59 CET! This is your final chance to submit your work to the congress, and no extensions can be given!
 

Find out more on the ECCMID website.

 

 

ECCMID hybrid registration fees

Not sure whether to book a hybrid or online-only ticket to ECCMID 2022?

Because of the current situation, ESCMID is happy to announce that onsite and online tickets are available for the same price during regular fee registration (until 16 March 2022), so you can book without risk.

Pre-ECCMID day highlights – February 23, 2022

For the upcoming Pre-ECCMID day on diagnostics, we are also featuring two new sessions highlighting two new ESCMID COVID-19 Guidelines! In addition, selected sessions will be simultaneously translated into Arabic, Mandarin, Spanish and Russian. Find out more on the ECCMID website.

The ECCMID 2022 Online Platform is now open!

We are pleased to announce the opening of the ECCMID 2022 Online Platform! If you have a valid ECCMID 2022 registration, you can now log in to the platform and start to explore the online side of ECCMID 2022, including the European Networking Corner and virtual Company Profiles.

Prevalence of post-acute COVID-19 syndrome at follow-up periods

This review aims to estimate the prevalence of persistent symptoms and signs at least 12 weeks after acute COVID-19 at different follow-up periods. It was found that a large proportion of patients experience PACS 3 to 12 months after recovery from the acute phase of COVD-19.

 

 

 

 

Nahoru